Faecal markers in the assessment of activity in inflammatory bowel disease

A Poullis, R Foster, TC Northfield… - Alimentary …, 2002 - Wiley Online Library
The fundamental pathological process behind ulcerative colitis and Crohn's disease is
intestinal inflammation. As the precise cause of this is not yet completely understood, current …

Emerging role of calprotectin in gastroenterology

A Poullis, R Foster, MA Mendall… - … of gastroenterology and …, 2003 - Wiley Online Library
Calprotectin is a calcium and zinc binding protein of the S100 family derived predominantly
from neutrophils and monocytes. It is detectable in body fluids and tissue samples and is …

Systematic review: does gastro‐oesophageal reflux disease progress?

M Fullard, JY Kang, P Neild, A Poullis… - Alimentary …, 2006 - Wiley Online Library
Background Gastro‐oesophageal reflux disease affects approximately 20% of western
populations. Barrett's oesophagus, associated with severe gastro‐oesophageal reflux …

Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk

A Poullis, R Foster, A Shetty, MK Fagerhol… - … Biomarkers & Prevention, 2004 - AACR
The mechanisms by which the lifestyle risk factors obesity, physical inactivity, and low fiber
intake predispose to colorectal cancer (CRC) are unclear. Chronic bowel inflammation …

[HTML][HTML] Efficacy of budesonide orodispersible tablets as induction therapy for eosinophilic esophagitis in a randomized placebo-controlled trial

…, AC García, E Rubio, P Hruz, S Brunner, A Poullis - Gastroenterology, 2019 - Elsevier
Background & Aims Swallowed topical-acting corticosteroids are recommended as first-line
therapy for eosinophilic esophagitis (EoE). Asthma medications not optimized for …

A new, highly sensitive assay for C-reactive protein can aid the differentiation of inflammatory bowel disorders from constipation-and diarrhoea-predominant functional …

AP Poullis, S Zar, KK Sundaram… - European journal of …, 2002 - journals.lww.com
Background Patients presenting to gastroenterology clinics with symptoms suggestive of
lower-bowel disorders often require extensive investigation to differentiate functional from …

Proton pump inhibitors are associated with elevation of faecal calprotectin and may affect specificity

A Poullis, R Foster, MA Mendall - European journal of …, 2003 - journals.lww.com
A direct comparison with faecal occult blood has revealed that faecal calprotectin is more
sensitive but less specific for the detection of colorectal neoplasia [3]. However, before …

Inflammatory bowel disease and exercise: results of a Crohn's and Colitis UK survey

…, H Robbins, S Rogers, S Clark, A Poullis - Frontline …, 2014 - fg.bmj.com
Background Over 250 000 people in the UK are affected with inflammatory bowel disease
(IBD) and approximately 10 000 new cases are diagnosed every year. These chronic bowel …

[HTML][HTML] Emerging role of novel biomarkers in the diagnosis of inflammatory bowel disease

AA Soubières, A Poullis - World journal of gastrointestinal …, 2016 - ncbi.nlm.nih.gov
There is currently no gold standard test for the diagnosis of inflammatory bowel disease
(IBD). Physicians must rely on a number of diagnostic tools including clinical and …

[HTML][HTML] COVID-19 infection causing residual gastrointestinal symptoms–a single UK centre case series

…, K Rafique, W Laband, B Shandro, A Poullis - Clinical …, 2022 - ncbi.nlm.nih.gov
Although COVID-19 was first recognised as an acute respiratory illness, extra-pulmonary
manifestations are increasingly being recognised. Acute gastrointestinal side effects have …